EUVIMEDEUVIMED entdecken
Crossref

Comparison of Effect of Intravenous Palonosetron Versus Ondansetron for the Prevention of Shivering in Parturients Undergoing Caesarean Section Under Subarachnoid Block

Pavithra C, Madhan V, G. B. Sumalatha, Ravichandra Dodawad

International Journal of Current Pharmaceutical Review and Research · 31.05.2026 · 18 (05)

DOI: 10.25258/ijcpr.18.5.195 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.05.2026. Verfasst von Pavithra C und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Shivering is a common complication in patients undergoing spinal anaesthesia for caesarean sections, with an incidence of 40–60%. It increases oxygen demand, hemodynamic stress, and postoperative discomfort. While 5-HT₃antagonists like ondansetron are known for antiemetic effects, recent studies suggest they may also reduce shivering. This study aimed to compare the efficacy of intravenous palonosetron (0.075 mg) versus ondansetron (8 mg) in preventing shivering during caesarean sections under subarachnoid block. The primary objective was to determine which drug offers superior shivering prevention with minimal side effects. Materials and Methods: A randomized, double-blinded study was conducted on 130 ASA I/II parturients undergoing elective caesarean sections under spinal anaesthesia. Participants were divided into two groups: Group A received ondansetron (8 mg IV), and Group B received palonosetron (0.075 mg IV) 10 minutes postspinal block. Shivering incidence and intensity (graded 0–4using the Tsai & Chu scale), hemodynamic parameters, and neonatal APGAR scores were recorded. Rescue tramadol (25 mg IV) was administered for grade ≥2 shivering. Statistical analysis included chi-square and t-tests.

Results

Palonosetron was significantly more effective, with 9.2% of patients experiencing shivering compared to 26.2% in the ondansetron group (p = 0.022). Grade 3 shivering occurred in 1.5% (palonosetron) vs. 7.7% (ondansetron). Only 4.6% of palonosetron patients required tramadol versus 20% in the ondansetron group (p = 0.016). Both drugs maintained hemodynamic stability and had no adverse effects on neonatal APGAR scores.

Conclusion

Palonosetron (0.075 mg IV) is more effective than ondansetron (8 mg IV) in preventing perioperative shivering, with lower incidence, reduced severity, and fewer rescue interventions. The study supports palonosetron as a safer, more effective alternative for shivering prophylaxis in caesarean sections under spinal anaesthesia, without compromising maternal or neonatal outcomes.

Zitieren

APA

C, P., V, M., Sumalatha, G. B., & Dodawad, R. (2026). Comparison of Effect of Intravenous Palonosetron Versus Ondansetron for the Prevention of Shivering in Parturients Undergoing Caesarean Section Under Subarachnoid Block. International Journal of Current Pharmaceutical Review and Research, 18(05). https://doi.org/10.25258/ijcpr.18.5.195

Vancouver

C P, V M, Sumalatha GB, Dodawad R. Comparison of Effect of Intravenous Palonosetron Versus Ondansetron for the Prevention of Shivering in Parturients Undergoing Caesarean Section Under Subarachnoid Block. International Journal of Current Pharmaceutical Review and Research. 2026;18(05). doi:10.25258/ijcpr.18.5.195

BibTeX
@article{C2026,
  author = {C, Pavithra and V, Madhan and Sumalatha, G. B. and Dodawad, Ravichandra},
  title = {Comparison of Effect of Intravenous Palonosetron Versus Ondansetron for the Prevention of Shivering in Parturients Undergoing Caesarean Section Under Subarachnoid Block},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {05},
  doi = {10.25258/ijcpr.18.5.195}
}
Kostenlos starten →